Germany, April 30 -- Germany based Viatris Healthcare GmbH has secured contract from DAK-Gesundheit for Pharmaceutical Products - Completion of a non -exclusive discount agreement according to Section 130a (8) SGB V for the active ingredient dydrogesteron estradiol, ATC G03FA14 for the time 01052023 - 30042025. The value of the contract is not disclosed.
Published by HT Digital Content Services with permission from Pivotal Sources....